Clinical Trials to Validate AI-Driven Drug Repurposing
Offered by Amyotrophic Lateral Sclerosis · Tampa, FL
About this opportunity
CWR seeks investigator-initiated, proof of concept, phase 1 or phase 2A clinical trials to validate AI-driven repurposing opportunities in any unsolved disease. Eligible trials must include AI-generated data as part of preclinical support, with preference for rare disease trials.
How to apply
Applications are handled on the funder's own website. Review the full guidelines and apply here: als.org/research/researchers/research-funding-opportunities. Confirm the deadline and eligibility directly with Amyotrophic Lateral Sclerosis before applying.
Is this grant a fit for your nonprofit?
Before you spend hours on an application, know whether it's worth it. Bespoke Grants scores any open RFP against your mission, budget, and service area — and finds the other funders you're missing. Free, no credit card.
Check my fit & find more grants →Other open opportunities from Amyotrophic Lateral Sclerosis
Amyotrophic Lateral Sclerosis currently lists 6 open opportunities in our index.
- Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)
- BRAIN Initiative: Preclinical Proof of Concept for Novel Recording and Modulation Technologies in the Human CNS (R18 - Clinical Trial Not Allowed)
- BRAIN Initiative: Preclinical Proof of Concept for Novel Recording and Modulation Technologies in the Human CNS (R18)
- Clinical Repurposing Research to Impact Veterans/Military
- Identify and Evaluate Potential Risk Factors for ALS
Frequently asked questions
- What is the deadline for Clinical Trials to Validate AI-Driven Drug Repurposing?
- The application deadline is June 26, 2026. Deadlines can change — always confirm directly with Amyotrophic Lateral Sclerosis before applying.
- How much funding is available?
- The award range is Up to $100K.
- Where do I apply?
- Applications are submitted through Amyotrophic Lateral Sclerosis's own website or process — see the "How to apply" section above.